Press Releases

October 3rd, 2006 XOMA to Humanize Attenuon's Novel Anti-Cancer Antibody (pdf)

October 28th, 2004 Attenuon Recieves NIH Grant to Study ATN-161 Analogs as Cancer Imaging Agents (pdf)

May 24th, 2004 Attenuon Announces Launch of ATN-224 Phase I Trial in Patients with Solid Tumors (pdf)

March 29th, 2004 Data from Preclinical Studies Examining Effect of ATN-161 on Organ and Skeletal Metastases of Breast Cancer Presented at American Association for Cancer Research (AACR) Annual Meeting (pdf)

February 24th, 2004 Attenuon, LLC and Kirin Brewery Co., Ltd. of Japan Announce Joint Research Collaboration (pdf)

January 30th, 2003 Attenuon, LLC Launches Phase I Trial of ATN-161 (pdf)